Goldman adds IMCD to conviction list while IMCD stock sits 3.57 percent below high

Published on 10/13/2026 at 10:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

IMCD reported EBITA of EUR 285 million in the first half of 2026, up 8 percent. IMCD stock costs EUR 101.30 on October 13, 2026, 3.57 percent below its high.

Goldman Sachs added IMCD to its October European Conviction List on October 1, 2026.
IMCD reported EUR 285 million of EBITA in the first half of 2026, up 8 percent on a constant currency basis.
IMCD stock was at EUR 101.30 at Lang & Schwarz on October 13, 2026, 3.57 percent below its 52-week high.
IMCD is scheduled to publish its first nine months 2026 results on November 5, 2026.

Editorial-Foto eines Handelsraums mit Börsenbildschirmen zu Euronext Amsterdam und AEX 25 — Börsen-Editorial zeigt Handelsraum mit Euronext Amsterdam Charts, Notierung von IMCD N.V., ISIN NL0010801007, Illustration mit AI erstellt.

IMCD (ISIN NL0010801007) was at EUR 101.30 at Lang & Schwarz on October 13, 2026 at 10:12 a.m. CEST, 3.57 percent below its 52-week high of EUR 105.05. Goldman Sachs added IMCD to its October European Conviction List on October 1, 2026, citing a possible turning point in volumes and support from the company’s specialized product mix, as Investing.com reported.

Three dated operating markers

On July 29, 2026, IMCD reported first-half EBITA of EUR 285 million, up 8 percent on a constant currency basis, and free cash flow of EUR 222 million. The figures came from the company’s 2026 half-year results call, published by Yahoo Finance.

On October 1, 2026, Goldman Sachs added IMCD to its European Conviction List for October. The bank said the specialized product mix could help pricing hold up better than expected, while improving economic data could support demand, according to Investing.com.

On October 13, 2026, the Lang & Schwarz quote placed IMCD at EUR 101.30, while the 52-week range stood at EUR 68.14 to EUR 105.05. The stock was therefore 48.73 percent above its 52-week low and 3.57 percent below its high.

What drives the margin debate?

IMCD’s first-half gross profit reached EUR 658 million, up 7 percent on a constant currency basis, while EBITA rose 8 percent. Gross profit as a percentage of revenue was 24.90 percent, down 0.70 percentage points from the comparable period, with acquisitions contributing to the decline, according to the Yahoo Finance transcript.

The same call recorded a 76.20 percent cash conversion margin and EUR 1.60 billion of debt at the end of June 2026. That combination gives the earnings story two sides: stronger operating growth and cash generation, but also a margin comparison affected by recent acquisitions.

Upcoming reporting dates

IMCD’s next scheduled milestone is the publication of its first nine months 2026 results on November 5, 2026. The company’s investor-relations calendar also lists full-year 2026 results for February 19, 2027, according to IMCD.

IMCD stock stays below its yearly high

IMCD operates as a global distributor and marketer of specialty chemicals and ingredients. Its Euronext Amsterdam listing uses the ticker IMCD, as confirmed by Global Banking and Finance.

At 10:12 a.m. CEST on October 13, 2026, IMCD was trading at EUR 101.30 at Lang & Schwarz, 3.57 percent below its 52-week high of EUR 105.05. The further course of trading is shown by the continuously updated real-time quote of IMCD stock.